Back to search

Article

Nirmatrelvir Resistant SARS-CoV-2 Variants with High Fitness in Vitro

2022-06-07

Abstract excerpt

The oral protease inhibitor nirmatrelvir is expected to play a pivotal role for prevention of severe cases of coronavirus disease 2019 (COVID-19). To facilitate monitoring of potentially emerging resistance, we studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape from nirmatrelvir. Resistant variants selected in cell culture harbored different combinations of substitutions in the SARS-CoV-2...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b2039cbf-35b6-5fb5-a48c-d39c63681db1
DOI
10.1101/2022.06.06.494921
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nirmatrelvir Resistant SARS-CoV-2 Variants with High Fitness in VitroDOI 10.1101/2022.06.06.494921
Select a neighboring publication to make it the new centre.